alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 9
<CIK> 0000768532
<NAME> FIRST COMMERCE BANCSHARES, INC.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                         131,309
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                28,528
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    379,849
<INVESTMENTS-CARRYING>                         270,012
<INVESTMENTS-MARKET>                           271,886
<LOANS>                                      1,121,239
<ALLOWANCE>                                     20,157
<TOTAL-ASSETS>                               2,028,012
<DEPOSITS>                                   1,574,544
<SHORT-TERM>                                   180,192
<LIABILITIES-OTHER>                             22,905
<LONG-TERM>                                     52,973
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,709
<OTHER-SE>                                     194,689
<TOTAL-LIABILITIES-AND-EQUITY>               2,028,012
<INTEREST-LOAN>                                 97,228
<INTEREST-INVEST>                               35,281
<INTEREST-OTHER>                                 3,990
<INTEREST-TOTAL>                               136,499
<INTEREST-DEPOSIT>                              55,315
<INTEREST-EXPENSE>                              66,393
<INTEREST-INCOME-NET>                           70,106
<LOAN-LOSSES>                                    6,839
<SECURITIES-GAINS>                               1,672
<EXPENSE-OTHER>                                 73,912
<INCOME-PRETAX>                                 33,385
<INCOME-PRE-EXTRAORDINARY>                      21,756
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    21,756
<EPS-PRIMARY>                                     1.60
<EPS-DILUTED>                                     1.60
<YIELD-ACTUAL>                                    7.98
<LOANS-NON>                                      3,429
<LOANS-PAST>                                       846
<LOANS-TROUBLED>                                 1,597
<LOANS-PROBLEM>                                  6,660
<ALLOWANCE-OPEN>                                19,017
<CHARGE-OFFS>                                    7,794
<RECOVERIES>                                     2,095
<ALLOWANCE-CLOSE>                               20,157
<ALLOWANCE-DOMESTIC>                            20,157
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
#### § 77.605 Breaking trailing cable and power cable connections.

Trailing cable and power cable connections between cables and to power sources shall not be made or broken under load.
§ 2003.5 Meetings (Article V). ( a ) *Purpose.* The primary purpose of ISCAP meetings is to discuss and bring formal resolution to matters before the Panel and carry out the functions listed in § 2003.3, Article III, of these bylaws.
( b ) *Frequency.* The Panel meets at the call of the Chair, who schedules meetings as necessary for the Panel to fulfill its functions in a timely manner. The Chair also convenes the ISCAP when requested by a majority of its member organizations.
( c ) *Quorum.* Panel meetings may be held only when a quorum is present. For this purpose, a quorum requires the presence of at least five primary or alternate members.
( d ) *Attendance.* As determined by the Chair, attendance at Panel meetings is limited to only the people necessary for the Panel to fulfill its functions in a complete and timely manner. The members may arrange briefings by substantive experts from individual departments or agencies, after consultation with the Chair.
( e ) *Agenda.* The Chair establishes the agenda for all meetings. Any member or the Executive Secretary may submit potential items for the agenda. Acting through the Executive Secretary, the Chair distributes the agenda and supporting materials to the members as soon as possible before a scheduled meeting.
( f ) *Minutes.* The Executive Secretary and staff prepare each meeting's minutes, and distribute draft minutes to each member. The minutes include a record of the members present at the meeting and the result of each vote. At each Panel meeting, the Chair reads or references the previous meeting's draft minutes. At that time the minutes are corrected, as necessary, approved by the membership, and certified by the Chair. The approved minutes are maintained among the Panel's records.
### §5757.1 Payment of expenses to obtain professional credentials

(a) An agency may use appropriated funds or funds otherwise available to the agency to pay for—

(1) expenses for employees to obtain professional credentials, including expenses for professional accreditation, State-imposed and professional licenses, and professional certification; and

(2) examinations to obtain such credentials.

(b) The authority under subsection (a) may not be exercised on behalf of any employee occupying or seeking to qualify for appointment to any position that is excepted from the competitive service because of the confidential, policy-determining, policy-making, or policy-advocating character of the position.

(Added Pub. L. 107–107, div. A, title XI, §1112(a), Dec. 28, 2001, 115 Stat. 1238.)

1 Another section 5757 is set out after this section.
This memorandum opinion was not selected for publi cation in the New Mexico Reports. Please see 1 Rule 12-405 NMRA for restrictions on the cita tion of unpublished memorandum opinions. Please 2 also note that this electronic memorandum opinion ma y contain computer-generated errors or other 3 deviations from the official paper version file d by the Court of Appeals and does not include the 4 filing date. 5 IN THE COURT OF APPEALS OF THE STATE OF NEW MEXICO 6 CITY OF DEMING, 7 Plaintiff-Appellee, 8

v. NO. 29,712 9 BILLY EDWARDS, 10 Defendant-Appellant. 11 APPEAL FROM THE DISTRICT COURT OF LUNA COUNTY 12 Daniel Viramontes, District Judge 13 Beall & Biehler PA 14 Mary T. Torres 15 Albuquerque, NM 16 for Appellee 17 Billy L. Edwards 18 Deming, NM 19 Pro se Appellant 20

MEMORANDUM OPINION 21 BUSTAMANTE, Judge. 22 Appellant, pro se, appeals from the di strict court’s order dismissing the 232 complaint on Appellee’s motion to dismiss. This Court filed a first notice of proposed 1 disposition proposing summary affirmance. Appellant filed two pleadings entitled 2 “Brief-in-Chief” and a “Brief-in-Chief/Me morandum.” However, these pleadings did 3 not rectify the problems with the docketing statement, as enumerated in the first 4 notice. Nor does the memorandum in opposition poi nt out any errors or fact in the law 5 cited in the first notice. “O ur courts have repeatedly he ld that, in summary calendar 6 cases, the burden is on the party opposing th e proposed disposition to clearly point out 7 errors in fact or law.” Hennessy v. Duryea , 1998-NMCA-036, ¶ 24, 124 N.M. 754, 8 955 P.2d 683. In addition, the first no tice warned Appellant that unless a 9 memorandum in opposition was filed that clear ly enumerated the reasons the district 10 court erred in granting Appellee’s motion to dismiss, and the authority in support of 11 each argument, this Court would proceed to affirm the district c ourt. Appellant has 12 not articulated clear legal issues applicable to the appeal, or cited to relevant case law. 13 See Clayton v. Trotter , 110 N.M. 369, 373, 796 P.2d 262, 266 (Ct. App. 1990) 14 (stating that this Court will review pro se arguments to the best of its ability, but 15 cannot respond to unintelligible arguments). 16 For these reasons, and those stated in the first notice of proposed disposition, 17 we affirm the district court. 18 IT IS SO ORDERED. 193 1 MICHAEL D. BUSTAMANTE, Judge 2 WE CONCUR: 3

4 JAMES J. WECHSLER, Judge 5

6 MICHAEL E. VIGIL, Judge 7
Robert Wessel D/B/A

SKYWAYVISIONS LLC DJI Inspire 1 POST-FLIGHT CHECK LIST: (June 12, 2015)

1. Motors powered off. 2. Aircraft powered off. 3. Individual propellers uninstalled and inspected for damage along with the airframe. Any propellers suspected of damage will be scheduled for closer inspection prior to use on next flight as per pre-flight inspection check list. 4. Propellers stored in travel case. 5. Gimbal is carefully uninstalled insuring not to accidently eject the SD card and replacing the electrical contact protective cap. 6. Gimbal placed in its protective box along with with the SD card in its slot and put in the travel

case. 7. Airframe inspected for damage and cleaned of any duct or debris. 8. Airframe placed on smooth surface and powered on. 9. Airframe placed in travel mode (landing gear up). 10.Airframe powered off. 11.Airframe returned to travel case. 12. Master and slave remote powered off. 13. Control tablets powered off as necessary, removed from remote controller mounts and stowed as required. 14. Master and slave remote antennas stowed and units returned to travel case.
# C_2010100EN.01003501.xml

| 17.4.2010 | EN | Official Journal of the European Union | C 100/35 |
| --- | --- | --- | --- |

17.4.2010

EN

Official Journal of the European Union

C 100/35

---

Judgment of the General Court of 2 March 2010 — Arcelor v Parliament and Council

(Case T-16/04) (1)

1

(Environment - Directive 2003/87/EC - Scheme for greenhouse gas emission allowance trading - Action for annulment - Lack of direct and individual concern - Action for damages - Admissibility - Sufficiently serious breach of a higher-ranking rule of law conferring rights on individuals - Right to property - Freedom to pursue a trade or profession - Proportionality - Equal treatment - Freedom of establishment - Legal certainty)

2010/C 100/52

Language of the case: English

Parties

Parties

Applicant: Arcelor SA (Luxembourg, Luxembourg) (represented by: W. Deselaers, B. Meyring and B. Schmitt-Rady and subsequently by W. Deselaers and B. Meyring, lawyers,)

Applicant:

Defendants: European Parliament (represented by: K. Bradley and M. Moore and subsequently by L. Visaggio and I. Anagnostopoulou, Agents) and Council of the European Union (represented by: B. Hoff-Nielsen and M. Bishop, subsequently by E. Karlsson and A. Westerhof Löfflerova and subsequently by A. Westerhof Löfflerova and K. Michoel, Agents)

Defendants:

Intervener in support of the defendants: European Commission (represented by: U. Wölker, Agent)

Intervener in support of the defendants:

Re:

Re:

Partial annulment of Directive 2003/87/EC of the European Parliament and of the Council of 13 October 2003 establishing a scheme for greenhouse gas emission allowance trading within the Community and amending Council Directive 96/61/EC (OJ 2003 L 275, p. 32), and compensation for the damage allegedly suffered by the applicant in consequence of the adoption of that directive

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Arcelor SA to bear its own costs and those incurred by the European Parliament and the Council of the European Union; |
| --- | --- |

2.

Orders Arcelor SA to bear its own costs and those incurred by the European Parliament and the Council of the European Union;

| 3. | Orders the European Commission to bear its own costs. |
| --- | --- |

3.

Orders the European Commission to bear its own costs.

---

(1)  OJ C 71, 20.3.2004.

1

---
§ 57.6401 Shunting. Except during testing— ( a ) Electric detonators shall be kept shunted until connected to the blasting line or wired into a blasting round;
( b ) Wired rounds shall be kept shunted until connected to the blasting line; and
( c ) Blasting lines shall be kept shunted until immediately before blasting.
January 10, 2011

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Page 35 

Table 15d. Drug Interactions between CCR5 Antagonist and Other Drugs (Updated January 10, 2011)

This table provides information relating to pharmacokinetic interactions between MVC and non-ARV drugs. For interactions among ARV agents and 

for dosing recommendations, please refer to Table 16b.

Concomitant Drug 

Class/Name CCR5 Antagonist

Effect on CCR5 Antagonist or 

Concomitant Drug 

Concentrations

Dosing Recommendations and Clinical Comments

Anticonvulsants

Carbamazepine

Phenobarbital

Phenytoin

MVC ↓ MVC possible If used without a strong CYP3A inhibitor, use MVC 600 mg BID or 

an alternative antiepileptic agent.

Antifungal

Itraconazole MVC ↑ MVC possible Dose: MVC 150 mg BID

Ketoconazole MVC MVC AUC ↑ 400% Dose: MVC 150 mg BID

Voriconazole MVC ↑ MVC possible Consider dose reduction to MVC 150 mg BID

Antimycobacterials

Clarithromycin MVC ↑ MVC possible Dose: MVC 150 mg BID

Rifabutin MVC ↓ MVC possible

If used without a strong CYP3A inducer or inhibitor, use MVC 300 

mg BID.

If used with a strong CYP3A inhibitor, use MVC 150 mg BID.

Rifampin MVC MVC AUC ↓ 64%

Coadministration is not recommended.

If coadministration is necessary use MVC 600 mg BID.

If coadministered with a strong CYP3A inhibitor, use MVC 300 mg 

BID.

Herbal Products

St. John’s wort MVC ↓ MVC possible Coadministration is not recommended.

Hormonal Contraceptives

Hormonal contraceptives MVC No significant effect on ethinyl 

estradiol or levonorgestrel Safe to use in combination

Narcotics/Treatment for Opioid Dependence

Methadone MVC No data

Acronyms: ARV = antiretroviral, AUC = area under the curve, BID = twice daily, CYP = cytochrome P, MVC = maraviroc

Table 15e. Drug Interactions between Integrase Inhibitor and Other Drugs 

(Updated January 10, 2011)

Concomitant Drug 

Class/Name Integrase Inhibitor Effect on Integrase Inhibitor or Concomitant Drug Concentrations Dosing Recommendations and Clinical Comments

Acid Reducers

Omeprazole RAL RAL AUC ↑ 212%, Cmax ↑ 315%, and 

Cmin ↑ 46% No dosage adjustment recommended

Antimycobacterials

Rifabutin RAL RAL AUC ↑ 19%, Cmax ↑ 39%, and 

Cmin ↓ 20% No dosage adjustment recommended

Rifampin RAL

RAL AUC ↓ 40% and Cmin ↓ 61% with 

RAL 400 mg

Rifampin with RAL 800 mg BID 

compared with RAL 400 mg BID 

alone: RAL AUC ↑ 27% and Cmin ↓ 

53% 

Dose: RAL 800 mg BID

Monitor closely for virologic response.

Hormonal Contraceptives

Hormonal contraceptives RAL No clinically significant effect Safe to use in combination

Narcotics/Treatment for Opioid Dependence

Methadone RAL No significant effect No dosage adjustment necessary

Acronyms: AUC = area under the curve, BID = twice daily, Cmax = maximum plasma concentration, Cmin = minimum plasma concentration, RAL = raltegravir
Exhibit 31.02

Citizens Financial Corp.

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of
2002

I, Thomas K. Derbyshire, Vice President, Treasurer and Principal Financial Officer of Citizens Financial Corp., certify that:

1. I have reviewed this annual report on Form 10-K of Citizens Financial Corp;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results in operations and cash flows of the
registrant as of, and for, the periods presented in this report.

4. The registrants other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer
and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent
functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.

Date: 3/14/06



/s/ Thomas K. DerbyshireThomas K. DerbyshireV.P., Treasurer & Principal Financial Officer
Heli Xpress, LLC

RE: Docket number FAA- 2010 - 1083 Current Exemption Number: 10158 from CFR (FAR section) Part: 120 100 Wy man ct Wi nston Salem, NC 27106 Phone: 336 - 768 - 9126 Helixpress@gmail.com I am seeking a n extension to the current exemption of Title 14 of the Code of Federal Regulations (CFR) Part 120. Currently FAA- 2010 - 1083 allows us for an exemption. Nothing has changed with the company or the drug and alcohol testing. Wewould like to extend the curren t exemption. Heli Xpress, LLC has two operating certificates for different operations and therefore is required by Part 120 to have a drug and alcohol program for each operating certificate. All of the employees and safety sensitive personnel perform the same jobs in both certificates and are covered by one drug and alcohol program for one certificate. There is no need for two drug and alcohol programs. The current exemption if extended would suffice.

Jared L Wa tkins
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Mid-War Developments in Civilian Family Allowances

              																	United States. Bureau of Labor Statistics					 and 	Waggaman, Mary T. (Mary Theresa). 						*Mid-War Developments in Civilian Family Allowances : Bulletin of the United States Bureau of Labor Statistics, No. 803*,												Washington, D.C: 								G.P.O., 										1944,									https://fraser.stlouisfed.org/title/4273,			accessed on September 21, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
Annual Bonus Plan



 






Exhibit 10.11




Annual Bonus Plan

Adopted by the Compensation Committee of the Board of Directors of

SFBC International, Inc.

On

May 17, 2005



For the 12-month period beginning April 1, 2005, the maximum annual bonus
payable to Drs. Krinsky and Holmes and Messrs. Hantman and Natan shall be 100%
of their respective base salaries. The annual bonus shall be comprised of the
following five independent components with the maximum amount payable under
each component equal to 20% of the executive’s base salary, based upon the
attainment of agreed upon targets:



1. Revenue;

2. Net income;

3. Earnings per share;

4. Stock price; and

5. Operational goals.
### §705. Relief pending review

When an agency finds that justice so requires, it may postpone the effective date of action taken by it, pending judicial review. On such conditions as may be required and to the extent necessary to prevent irreparable injury, the reviewing court, including the court to which a case may be taken on appeal from or on application for certiorari or other writ to a reviewing court, may issue all necessary and appropriate process to postpone the effective date of an agency action or to preserve status or rights pending conclusion of the review proceedings.

(Pub. L. 89–554, Sept. 6, 1966, 80 Stat. 393.)

| Derivation | U.S. Code | Revised Statutes and Statutes at Large |
| --- | --- | --- |
| | 5 U.S.C. 1009(d). | June 11, 1946, ch. 324, §10(d), 60 Stat. 243. |

Statutes at Large

Standard changes are made to conform with the definitions applicable and the style of this title as outlined in the preface of this report.
#### § 1908.24 [Reserved]